Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels
about
Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice.Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantationPreclinical modeling of hematopoietic stem cell transplantation - advantages and limitations.Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.Protein dysregulation in graft versus host disease.B-cell targeting in chronic Graft-versus-Host disease.Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results.Successful treatment of refractory pure red cell aplasia with bortezomib after allogeneic haematopoietic cell transplantation in a patient with alpha-beta subcutaneous panniculitis-like T cell lymphoma.Cytokine mediators of chronic graft-versus-host disease.
P2860
Q33792598-4F2C0A2F-1891-43AD-AB26-EB5DD93E4DD6Q35586614-6E12C47C-E810-45DF-8BBB-FB1FB47D0EE1Q38660463-AC27E19B-749C-4C0B-9FCB-0212487B9B43Q48347965-7848F59A-8FBB-446D-868A-735C8A4F9CBDQ49228781-2391B3A6-893C-44D3-A020-13F3938DAC40Q50044417-693A8F64-6D2B-4FB7-A640-42CCDEEF3FE7Q50078364-15B9744E-D7B9-4641-812B-3A512AF67C6FQ50441140-F69EE683-866A-49FD-9C65-87C33BE5E4C9Q50915048-1DA3262C-9FA3-47A5-94C2-AFD570B1E106
P2860
Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Therapeutic benefit of bortezo ...... ated with interleukin-6 levels
@ast
Therapeutic benefit of bortezo ...... ated with interleukin-6 levels
@en
Therapeutic benefit of bortezo ...... ated with interleukin-6 levels
@nl
type
label
Therapeutic benefit of bortezo ...... ated with interleukin-6 levels
@ast
Therapeutic benefit of bortezo ...... ated with interleukin-6 levels
@en
Therapeutic benefit of bortezo ...... ated with interleukin-6 levels
@nl
prefLabel
Therapeutic benefit of bortezo ...... ated with interleukin-6 levels
@ast
Therapeutic benefit of bortezo ...... ated with interleukin-6 levels
@en
Therapeutic benefit of bortezo ...... ated with interleukin-6 levels
@nl
P2093
P2860
P1476
Therapeutic benefit of bortezo ...... ated with interleukin-6 levels
@en
P2093
Arta Monjazeb
Chien-Chun Steven Pai
Christine Mall
Hui-Hua Hsiao
Joseph Tellez
Mehrdad Abedi
Mingyi Chen
Takeshi Hagino
William J Murphy
P2860
P304
P356
10.1016/J.BBMT.2014.07.022
P577
2014-07-23T00:00:00Z